Literature DB >> 11708841

Positive inotropic and negative lusitropic effect of angiotensin II: intracellular mechanisms and second messengers.

M A Salas1, M G Vila-Petroff, J Palomeque, E A Aiello, A Mattiazzi.   

Abstract

In the cat ventricle angiotensin II exerts a positive inotropic effect produced by an increase in intracellular calcium associated with a prolongation of relaxation. The signaling cascades involved in these effects as well as the subcellular mechanisms of the negative lusitropic effect are still not clearly defined. The present study was directed to investigate these issues in cat papillary muscles and isolated myocytes. The functional suppression of the sarcoplasmic reticulum (SR) with either 0.5 microm ryanodine or 0.5 microm ryanodine plus 1 microm thapsigargin or the preincubation of the myocytes with the specific inhibitor of the inositol 1,4,5-triphosphate (IP3) receptors [diphenylborinic acid, ethanolamine ester (2-APB), 5-50 microm] did not prevent the positive inotropic effect and the increment in Ca2+ transient produced by 1 microm angiotensin II. In contrast, protein kinase C (PKC) inhibitors, chelerythrine (20 microm) and calphostin C (1 microm) completely inhibited both, the angiotensin II-induced increase in L-type calcium current and positive inotropic effect. The prolongation of half relaxation time produced by 0.5 microm angiotensin II [207+/-15.4 msec (control) to 235+/-19.98 msec (angiotensin II), P<0.05] was completely blunted by PKC inhibition. This antirelaxant effect, which was independent of intracellular pH changes, was associated with a prolongation of the action potential duration and was preserved after either the inhibition of the SR and the SR Ca2+ ATPase (ryanodine plus thapsigargin) or of the reverse mode of the Na+/Ca2+ exchanger (KB-R7943, 5 microm). We conclude that in feline myocardium the positive inotropic and negative lusitropic effects of angiotensin II are both entirely mediated by PKC without any significant participation of the IP3 limb of the phosphatidylinositol/phospholipase C cascade. The results suggest that the antirelaxant effect of angiotensin II might be determined by the decrease in Ca2+ efflux through the Na+/Ca2+ exchanger produced by the angiotensin II-induced prolongation of the action potential duration. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708841     DOI: 10.1006/jmcc.2001.1460

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  12 in total

1.  Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation.

Authors:  Carlos A Valverde; Cecilia Mundiña-Weilenmann; Matilde Said; Paola Ferrero; Leticia Vittone; Margarita Salas; Julieta Palomeque; Martín Vila Petroff; Alicia Mattiazzi
Journal:  J Physiol       Date:  2004-11-04       Impact factor: 5.182

2.  Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect.

Authors:  Adelino F Leite-Moreira; Paulo Castro-Chaves; Pedro Pimentel-Nunes; Alexandre Lima-Carneiro; Miguel S Guerra; João Bruno Soares; João Ferreira-Martins
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.

Authors:  Rebeca E Nuñez; Sabzali Javadov; Nelson Escobales
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-09-20       Impact factor: 2.557

4.  Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

Authors:  Xintong Dong; C Amelia Sumandea; Yi-Chen Chen; Mary L Garcia-Cazarin; Jiang Zhang; C William Balke; Marius P Sumandea; Ying Ge
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

5.  The increased angiotensin II (type 1) receptor density in myocardium of type 2 diabetic patients is prevented by blockade of the renin-angiotensin system.

Authors:  H Reuter; C Adam; S Grönke; C Zobel; K F Frank; J Müller-Ehmsen; J Brabender; R H G Schwinger
Journal:  Diabetologia       Date:  2006-10-19       Impact factor: 10.122

6.  Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity.

Authors:  Manlio Vinciguerra; Maria Paola Santini; William C Claycomb; Andreas G Ladurner; Nadia Rosenthal
Journal:  Aging (Albany NY)       Date:  2009-12-10       Impact factor: 5.682

7.  Angiotensin II and ischemic preconditioning synergize to improve mitochondrial function while showing additive effects on ventricular postischemic recovery.

Authors:  Rebeca E Nuñez; Miriam Castro; Sabzali Javadov; Nelson Escobales
Journal:  J Cardiovasc Pharmacol       Date:  2014-08       Impact factor: 3.105

8.  Role of phosphoinositide 3-kinase {alpha}, protein kinase C, and L-type Ca2+ channels in mediating the complex actions of angiotensin II on mouse cardiac contractility.

Authors:  Wenbin Liang; Gavin Y Oudit; Mikin M Patel; Ajay M Shah; James R Woodgett; Robert G Tsushima; Michael E Ward; Peter H Backx
Journal:  Hypertension       Date:  2010-08-09       Impact factor: 10.190

Review 9.  Nuclear calcium in cardiac myocytes.

Authors:  Senka Ljubojevic; Donald M Bers
Journal:  J Cardiovasc Pharmacol       Date:  2015-03       Impact factor: 3.105

Review 10.  Regulation of the cardiac sodium/bicarbonate cotransporter by angiotensin II: potential Contribution to structural, ionic and electrophysiological myocardial remodelling.

Authors:  Ernesto Alejandro Aiello; Verónica Celeste De Giusti
Journal:  Curr Cardiol Rev       Date:  2013-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.